Back
Vista Energy SAB de CV Vs. Denali Therapeutics Industry Stock Comparison
Buy
74
VIST
Vista Energy SAB de CV
Last Price:
46.95
Seasonality Move:
24.91%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.74
Seasonality Move:
17.79%
Buy
74
Vista Energy SAB de CV (VIST)
is a Buy
Is Vista Energy SAB de CV a Buy, Sell or Hold?
- The current Vista Energy SAB de CV [VIST] share price is $47.69. The Score for VIST is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- VIST is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VIST Stock Price Chart
What is Vista Energy SAB de CV's stock price today?
-
The Vista Energy SAB de CV share price today is $47.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIST is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.
VIST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 49.32 | Sell |
| Chaikin Money Flow: | 465863 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.26 - 50.6) | Sell |
| Bollinger Bands (100): | (43.45 - 48.63) | Buy |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.67 | Buy |
| Relative Strength Index (14 RSI): | 77.92 | Buy |
| Chaikin Money Flow: | 34344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.24 - 27.72) | Buy |
| Bollinger Bands (100): | (18.96 - 25.08) | Buy |
VIST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.06 | Buy |
| 20-day SMA: | 48.84 | Sell |
| 50-day SMA: | 47.11 | Buy |
| 200-day SMA: | 40.61 | Buy |
| 8-day EMA: | 47.55 | Buy |
| 20-day EMA: | 47.94 | Sell |
| 50-day EMA: | 47.19 | Buy |
| 200-day EMA: | 41.1 | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28 | Buy |
| 20-day SMA: | 26.04 | Buy |
| 50-day SMA: | 24.18 | Buy |
| 200-day SMA: | 20.53 | Buy |
| 8-day EMA: | 28.54 | Buy |
| 20-day EMA: | 26.57 | Buy |
| 50-day EMA: | 24.56 | Buy |
| 200-day EMA: | 22.12 | Buy |
Vista Energy SAB de CV Earnings Growth & VIST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.47 per share, an increase this year of $1.26 per share, and an increase next year of $1.57 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Vista Energy SAB de CV Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||